Summarecon Agung Future Growth
Future criteria checks 0/6
Summarecon Agung's revenue and earnings are forecast to decline at 8.1% and 7.9% per annum respectively. EPS is expected to decline by 7.8% per annum. Return on equity is forecast to be 8.3% in 3 years.
Key information
-7.9%
Earnings growth rate
-7.8%
EPS growth rate
Real Estate earnings growth | -3.7% |
Revenue growth rate | -8.1% |
Future return on equity | 8.3% |
Analyst coverage | Good |
Last updated | 26 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 7,660,780 | 852,050 | 834,700 | 1,365,575 | 5 |
12/31/2025 | 7,512,853 | 1,017,086 | 914,300 | 1,150,225 | 6 |
12/31/2024 | 8,493,325 | 1,047,766 | 1,119,000 | 1,521,075 | 7 |
9/30/2024 | 9,133,923 | 1,046,655 | 226,752 | 359,903 | N/A |
6/30/2024 | 9,339,049 | 1,077,617 | 739,014 | 869,318 | N/A |
3/31/2024 | 7,293,139 | 935,644 | 1,116,947 | 1,243,835 | N/A |
12/31/2023 | 6,658,783 | 765,970 | 1,285,819 | 1,397,969 | N/A |
9/30/2023 | 6,573,763 | 968,726 | 1,595,431 | 1,678,832 | N/A |
6/30/2023 | 5,983,046 | 812,804 | 1,650,325 | 1,715,853 | N/A |
3/31/2023 | 5,749,118 | 722,052 | 1,665,155 | 1,720,074 | N/A |
12/31/2022 | 5,719,396 | 625,377 | 2,612,985 | 2,656,645 | N/A |
9/30/2022 | 5,989,893 | 462,944 | 3,111,098 | 3,135,476 | N/A |
6/30/2022 | 5,838,303 | 469,776 | 3,144,542 | 3,168,450 | N/A |
3/31/2022 | 5,966,889 | 461,338 | 3,408,236 | 3,441,093 | N/A |
12/31/2021 | 5,567,913 | 323,709 | 2,408,191 | 2,443,281 | N/A |
9/30/2021 | 5,559,606 | 362,528 | 1,785,805 | 1,639,193 | N/A |
6/30/2021 | 5,306,791 | 278,173 | 1,404,598 | 1,346,312 | N/A |
3/31/2021 | 5,061,220 | 180,209 | 353,973 | 341,185 | N/A |
12/31/2020 | 5,029,984 | 179,835 | -73,468 | -22,932 | N/A |
9/30/2020 | 4,793,345 | 188,125 | -686,939 | -374,497 | N/A |
6/30/2020 | 5,452,381 | 376,171 | -547,375 | -281,369 | N/A |
3/31/2020 | 5,920,199 | 509,779 | 30,237 | 288,480 | N/A |
12/31/2019 | 5,941,626 | 514,984 | 276,300 | 504,744 | N/A |
9/30/2019 | 6,050,994 | 559,968 | -227,728 | 24,163 | N/A |
6/30/2019 | 5,669,095 | 519,353 | -105,180 | 126,061 | N/A |
3/31/2019 | 5,524,785 | 449,116 | -225,747 | -11,650 | N/A |
12/31/2018 | 5,661,360 | 448,710 | -329,563 | -128,735 | N/A |
9/30/2018 | 5,664,985 | 445,966 | -136,700 | -12,016 | N/A |
6/30/2018 | 5,603,952 | 379,977 | N/A | -271,821 | N/A |
3/31/2018 | 5,608,611 | 332,035 | N/A | -319,492 | N/A |
12/31/2017 | 5,640,752 | 362,063 | N/A | -378,919 | N/A |
9/30/2017 | 5,778,610 | 373,496 | N/A | -7,548 | N/A |
6/30/2017 | 5,780,327 | 347,605 | N/A | 191,540 | N/A |
3/31/2017 | 5,580,695 | 355,234 | N/A | 121,968 | N/A |
12/31/2016 | 5,397,949 | 311,666 | N/A | 34,709 | N/A |
9/30/2016 | 4,741,240 | 105,514 | N/A | -6,474 | N/A |
6/30/2016 | 5,344,575 | 350,454 | N/A | -388,190 | N/A |
3/31/2016 | 5,724,710 | 635,626 | N/A | -606,313 | N/A |
12/31/2015 | 5,623,561 | 855,186 | N/A | -20,685 | N/A |
9/30/2015 | 6,361,326 | 1,319,994 | N/A | 1,547,286 | N/A |
6/30/2015 | 6,261,149 | 1,371,414 | N/A | 804,968 | N/A |
3/31/2015 | 5,764,410 | 1,357,885 | N/A | 1,040,134 | N/A |
12/31/2014 | 5,756,984 | 1,385,078 | N/A | 131,102 | N/A |
9/30/2014 | 4,926,431 | 1,094,673 | N/A | -2,065,806 | N/A |
6/30/2014 | 4,262,430 | 1,033,509 | N/A | -836,561 | N/A |
3/31/2014 | 4,181,113 | 1,056,624 | N/A | -76,437 | N/A |
12/31/2013 | 4,093,789 | 1,102,177 | N/A | -717 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SMRA's earnings are forecast to decline over the next 3 years (-7.9% per year).
Earnings vs Market: SMRA's earnings are forecast to decline over the next 3 years (-7.9% per year).
High Growth Earnings: SMRA's earnings are forecast to decline over the next 3 years.
Revenue vs Market: SMRA's revenue is expected to decline over the next 3 years (-8.1% per year).
High Growth Revenue: SMRA's revenue is forecast to decline over the next 3 years (-8.1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SMRA's Return on Equity is forecast to be low in 3 years time (8.3%).